CClinicalTrials.gg
Status unknownNCT05602753Updated Nov 4, 2022

Smoking Cessation Study

An observational study in Smoking Cessation and Arthropathy, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. Status unknown at 1 site in Canada. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2022-11-04.

Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre · Observational

The sponsor has not verified this record recently (last verified Nov 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The primary outcome of this study is to determine the true incidence of smokers among patients undergoing joint replacement and secondly, what percent are able to quit smoking before surgery under a structured cessation program with carbon monoxide breath testing. The investigators hypothesize that self-reported smoking status is underreported and that routine carbon monoxide breath testing will improve abstinence rates at the time of surgery.

Read the detailed description

This study looks at patients who have been referred to our clinic for a potential hip and knee joint replacement surgery. Once it has been determined that the patient requires surgical replacement of either their hip or knee and is placed on our surgical waitlist, the patient will be asked if he or she would like to participate in the study. The investigators would ask all patients, both self-declared smokers and non-smokers, to participate. This study would include completing a smoking history questionnaire and a noninvasive carbon monoxide breath test. While smoking status is already assessed in the McGill University Health Centre preoperative questionnaire, the investigators intend on expanding these questions in study participants to better quantify their nicotine exposure.

02

Conditions studied

  • Smoking Cessation
  • Arthropathy

Browse trials for

03

In context

Joint Diseases

712 studies on the registry are indexed under Joint Diseases; 127 are open to participants now.

This study's planned enrollment of 300 is above the median of 100 across 216 observational studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre is the lead sponsor of 414 studies on the registry; 106 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who have been referred to our outpatient orthopaedic clinic for a potential hip and knee joint replacement and have been placed on our surgical waitlist for surgery.

Inclusion criteria

  • Adults ages 18-85 who require a primary total hip or knee replacement
  • Any gender
  • Smokers and non-smokers
  • Osteoarthritis, rheumatoid arthritis, avascular necrosis

Exclusion criteria

Exclusion Criteria:

  • Patients who require revision surgery
  • Previous fracture to affected area
  • Emergency surgery
  • Patients who do not understand, read or communicate in either French or English
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Smokers

    All patients who participate in the study will complete the smoking history questionnaire and the carbon monoxide breath test. All patients with positive carbon monoxide breath test indicative of active nicotine exposure will be provided a structured smoking cessation program that includes information, counseling from their surgeon, or a trained health care professional and referral to a smoking cessation program.

    Behavioral: Lifestyle Counseling

  • Non-Smokers

    Subjects who self-declared as non-smokers

  • Declared non-smokers with elevated Co2

    subjects who self-declared as non-smokers but who tested positive for elevated Co2,

Interventions

  • BehavioralLifestyle Counseling

    Referring to Stop smoking hotline, given pamphlets to encourage quitting smoking, pharmacy guidance, and possible referral to smoking cessation clinic.

06

What researchers measure

Primary outcomes

  1. True incidence of smokers among patients undergoing joint replacement

    The percentage of subjects who declare themselves as smokers and non-smokers with elevated Co2 levels.

    Time frame: 15 minutes

Secondary outcomes

  1. To determine the incidence of patients who successfully quit smoking prior to surgery.

    The percentage of subjects who were able to quit smoking under a structured cessation program with Carbon monoxide breath testing.

    Time frame: 20 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05602753
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Responsible party
Adam Hart (Principal Investigator, Staff Orthopaedic Surgeon, McGill University Health Centre/Research Institute of the McGill University Health Centre) — Principal investigator
First posted
Nov 2, 2022
Start date
Feb 18, 2021
Primary completion
Jan 31, 2025 (estimated)
Completion
Jan 31, 2025 (estimated)
Last update
Nov 4, 2022

Study contacts

Adam Hart, MD
Contact
adam.hart@mgcill.ca
514-934-1934 ext. 43040
Karen Smith, CRA
Contact
karen.smith@muhc.mcgill.ca
514-934-1934 ext. 43040

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion